Full Text
PIN20 A COST BENEFIT ANALYSIS OF ANTI-RETROVIRAL (ARVS) DRUGS IN THE TREATMENT OF HIV IN UGANDA

Abstract

Authors

A. Mwanje F. Kangenyi

Back to Volume 14, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×